Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2026-01-06 @ 8:18 AM
Study NCT ID:
NCT02998567
Status:
RECRUITING
Last Update Posted:
2025-08-17
First Post:
2016-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CCR4420
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None